EnteraSense secures $4M in funding for bleed-detecting GI tract capsule — 4 insights

EnteraSense secured $4 million (€3.5 million) in funding for its gastrointestinal tract bleed-detecting capsule, Med-Tech Innovation News reports.

Advertisement

Here’s what you should know:

1. The capsule monitors unexpected bleeding in postsurgical patients.

2. If a physician suspects GI bleeding, the capsule detects it quickly.

3. EnteraSense won a European Union Horizon 2020 grant and secured private investor funding.

4. EnteraSense will conduct in-human studies in 2019, with the goal of earning regulatory approval in 2020.

More articles on gastroenterology:
The PE arms race — From the deal heard round the world to what’s next in GI
The strategy behind Pardee UNC’s $16M ASC
ASC supply chain tip of the day: Find an accountability structure

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • Miami-based Gastro Health has finalized a partnership with Digestive Disease Physicians, an Alexandria, Va.-based gastroenterology practice, according to an April…

  • Birmingham (Ala.) Gastroenterology has opened a clinic in Jasper, Ala., expanding access to digestive health services in the region, the…

  • Premier Health Partners has acquired Dayton, Ohio-based Digestive Specialists, according to a notice posted on the website of law firm…

Advertisement

Comments are closed.